Publications by authors named "Matthew Cooney"

Claim this Profile
E
Exploring the indications, failures, and treatment of complications after a C2 to pelvis fusion.
Nathan J Lee, Fthimnir M Hassan, Ted Shi, Anastasia Ferraro, Matthew Cooney

Spine Deform· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does an improvement in cord-level intraoperative neuromonitoring data lead to a reduced risk for postoperative neurologic deficit in spine deformity surgery?
Nathan J Lee, Lawrence G Lenke, Mitchell Yeary, Alexandra Dionne, Chidebelum Nnake, Matthew Cooney

Spine Deform· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel Preoperative Scoring System to Accurately Predict Cord-Level Intraoperative Neuromonitoring Data Loss During Spinal Deformity Surgery: A Machine-Learning Approach.
Nathan J Lee, Lawrence G Lenke, Varun Arvind, Ted Shi, Alexandra C Dionne, Matthew Cooney

J Bone Joint Surg Am· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The distribution of esophageal cancer patients enrolled in care at the Uganda Cancer Institute by sub-regions, districts and ethnicity.
Siraji Obayo, Yusuf Mulumba, Cheryl L Thompson, Michael K Gibson, Matthew M Cooney

Afr Health Sci· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring Barriers to Pediatric Cancer Clinical Trials: The Role of a Networked, Just-in-Time Study Program.
Zachary Rivers, Ben Hyde, Karyn Ronski, Duncan Stearns, Stephanie Toll, Matthew Cooney

Clin Ther· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathological characteristics and treatment outcomes of oesophageal cancer patients in Uganda.
Siraji Obayo, Yusuf Mulumba, Cheryl L Thompson, Michael K Gibson, Matthew M Cooney

Ecancermedicalscience· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Operational Metrics for the ELAINE 2 Study Combining a Traditional Approach With a Just-in-TIME Model.
Sibel Blau, Julio Antonio Peguero, Halle C F Moore, Ian Churchill Anderson, Minal A Barve, Matthew M Cooney

JCO Clin Cancer Inform· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and outcomes of patients with multiple myeloma at the Uganda Cancer Institute.
Clement D Okello, Yusuf Mulumba, Abrahams Omoding, Henry Ddungu, Kristen Welch, Matthew M Cooney

Afr Health Sci· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Forensic isoscapes based on intra-individual temporal variation of O and Pb/Pb in human teeth.
Laura A Regan, Nathan W Bower, Samuel J Brown, Craig C Lundstrom, Gideon Bartov, Matthew D Cooney

Forensic Sci Res· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationships between expression of , mitochondrial bioenergetics, and fatigue among patients with prostate cancer.
Chao-Pin Hsiao, Mei-Kuang Chen, Martina L Veigl, Rodney Ellis, Matthew Cooney

Cancer Manag Res· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II study evaluating the safety and clinical efficacy of temsirolimus and bevacizumab in patients with chemotherapy refractory metastatic castration-resistant prostate cancer.
Pedro C Barata, Matthew Cooney, Prateek Mendiratta, Ruby Gupta, Robert Dreicer

Invest New Drugs· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Ketoconazole plus Lenalidomide in patients with Castration-Resistant Prostate Cancer (CRPC): results of an open-label phase II study.
Pedro C Barata, Matthew Cooney, Prateek Mendiratta, Allison Tyler, Robert Dreicer

Invest New Drugs· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the impact of the genitourinary multidisciplinary tumour board: Should every cancer patient be discussed as standard of care?
Kyle Scarberry, Lee Ponsky, Edward Cherullo, William Larchian, Donald Bodner, Matthew Cooney

Can Urol Assoc J· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insights into Geographic and Temporal Variation in Fatty Acid Composition of Croton Nuts Using ATR-FTIR.
Nathan W Bower, Murphy G Brasuel, Eli Fahrenkrug, Matthew D Cooney

Int J Anal Chem· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 study of OSI-906 (linsitinib, an insulin-like growth factor receptor-1 inhibitor) in patients with asymptomatic or mildly symptomatic (non-opioid requiring) metastatic castrate resistant prostate cancer (CRPC).
Pedro Barata, Matthew Cooney, Allison Tyler, John Wright, Robert Dreicer

Invest New Drugs· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial.
Christos E Kyriakopoulos, Yu-Hui Chen, Michael A Carducci, Glenn Liu, David F Jarrard, Matthew M Cooney

J Clin Oncol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seven-Month Prostate-Specific Antigen Is Prognostic in Metastatic Hormone-Sensitive Prostate Cancer Treated With Androgen Deprivation With or Without Docetaxel.
Lauren C Harshman, Yu-Hui Chen, Glenn Liu, Michael A Carducci, David Jarrard, Matthew Cooney

J Clin Oncol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate Cancer Burden at the Uganda Cancer Institute.
Fred Okuku, Jackson Orem, George Holoya, Chris De Boer, Cheryl L Thompson, Matthew M Cooney

J Glob Oncol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial.
William D Tap, Robin L Jones, Brian A Van Tine, Bartosz Chmielowski, Anthony D Elias, Matthew M Cooney

Lancet· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
National Trends of Local Ablative Therapy Among Young Patients With Small Renal Masses in the United States.
Jonathan E Kiechle, Robert Abouassaly, Marc C Smaldone, Nilay D Shah, Shan Dong, Matthew M Cooney

Urology· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upper gastrointestinal diseases in patients for endoscopy in South-Western Uganda.
Siraji Obayo, Conrad Muzoora, Ponsiano Ocama, Matthew M Cooney, Tony Wilson

Afr Health Sci· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer.
Christopher J Sweeney, Yu-Hui Chen, Michael Carducci, Glenn Liu, David F Jarrard, Matthew M Cooney

N Engl J Med· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of hypercoagulable events after image-guided percutaneous cryoablation of renal tumors: a single-center experience.
Jason B Hartman, Nicholas Bhojwani, David J Corn, Matthew M Cooney, John Haaga

J Vasc Interv Radiol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I trial of pomalidomide given for patients with advanced solid tumors.
Matthew M Cooney, Charles Nock, Joseph Bokar, Smitha Krishnamurthi, Joseph Gibbons

Cancer Chemother Pharmacol· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I trial of sunitinib and gemcitabine in patients with advanced solid tumors.
Joanna M Brell, Smitha S Krishnamurthi, Linda Rath, Joseph A Bokar, Panayiotis Savvides, Matthew M Cooney

Cancer Chemother Pharmacol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis